{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38217017", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["23", "10.1186/s13643-023-02446-4"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "12"}], "Journal": {"ISSN": "2046-4053", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "12"}}, "Title": "Systematic reviews", "ISOAbbreviation": "Syst Rev"}, "ArticleTitle": "Renal-protective effects of Chinese medicinal herbs and compounds for diabetic kidney disease in animal models: protocol for systematic review and meta-analysis.", "Pagination": {"StartPage": "23", "MedlinePgn": "23"}, "Abstract": {"AbstractText": ["Diabetic kidney disease (DKD) is a common and severe complication of diabetes that can lead to end-stage renal disease with no cure. The first-line drugs recommended by clinical guidelines fail to achieve satisfactory effects for people with DKD. A Chinese herbal medicine Tangshen Qushi Formula (TQF) shows preliminary efficacy and safety in preserving renal function for people with DKD, but the effects on comprehensive renal outcomes remain unclear. We will conduct a systematic review and meta-analysis to evaluate the effects of TQF herbs and their compounds identified from ultra-high performance liquid chromatography-MS/MS in diabetic animal models with renal outcomes.", "This protocol complies with the guideline Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols. We will include studies investigating the effects of TQF herbs and compounds on diabetic rats or mice with renal outcomes. Six electronic databases will be searched from their inception to February 2023. Quality assessment will be conducted using SYRCLE's risk of bias tool. Standardized or weighted mean differences will be estimated for renal outcomes (creatinine, urea, proteinuria, histological changes, oxidative stress, inflammation, and kidney fibrosis). Data will be pooled using random-effects models. Heterogeneity across studies will be expressed as I<sup>2</sup>. Sensitivity analyses will explore treatment effects in adjusted models and within subgroups. Funnel plots and Egger's test will be used to explore publication bias.", "The results of this review will provide valuable insights into the potential effects of TQF in managing DKD. The limitation is that the included studies will be animal studies from specific databases, and the interpretation of the findings must be cautious.", "PROSPERO CRD42023432895. Registered on 19 July 2023 ( https://www.crd.york.ac.uk/PROSPERO/#recordDetails )."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Liu", "ForeName": "Meifang", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia."}], "LastName": "Di", "ForeName": "Yuan Ming", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia."}], "LastName": "Zhang", "ForeName": "Anthony Lin", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Second Clinical College of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Chen", "ForeName": "Junhui", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Second Clinical College of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Wang", "ForeName": "Ruobing", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Research Department for New Drug Development and Authentication of Chinese Medicines, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Huang", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}, {"Identifier": [], "Affiliation": "Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China."}], "LastName": "Zhang", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia. charlie.xue@rmit.edu.au."}], "LastName": "Xue", "ForeName": "Charlie Changli", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. liuxusheng@gzucm.edu.cn."}, {"Identifier": [], "Affiliation": "Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. liuxusheng@gzucm.edu.cn."}], "LastName": "Liu", "ForeName": "Xusheng", "Initials": "X"}], "GrantList": [{"GrantID": "SZ2021ZZ43", "Agency": "The State Key Laboratory of Dampness Syndrome of Chinese Medicine in Guangdong Provincial Hospital of Chinese Medicine", "Country": ""}, {"GrantID": "202206010076", "Agency": "Guangzhou Municipal Science and Technology Project", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Syst Rev", "NlmUniqueID": "101580575", "ISSNLinking": "2046-4053"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["complications", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Diabetic Nephropathies"}, {"QualifierName": [], "DescriptorName": "Kidney"}, {"QualifierName": [], "DescriptorName": "Meta-Analysis as Topic"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["methods"], "DescriptorName": "Systematic Reviews as Topic"}, {"QualifierName": [], "DescriptorName": "Tandem Mass Spectrometry"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37(10):2864\u20132883. doi: 10.2337/dc14-1296.", "ArticleIdList": ["10.2337/dc14-1296", "PMC4170131", "25249672"]}, {"Citation": "Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2016;5(1):49\u201356.", "ArticleIdList": ["PMC5297507", "28197499"]}, {"Citation": "Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, et al. US Renal Data System 2020 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2021;77(4 Suppl 1):A7\u2013a8. doi: 10.1053/j.ajkd.2021.01.002.", "ArticleIdList": ["10.1053/j.ajkd.2021.01.002", "PMC8148988", "33752804"]}, {"Citation": "Yang F, Liao M, Wang P, Liu Y. Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China. BMJ Open. 2021;11(2):e039653. doi: 10.1136/bmjopen-2020-039653.", "ArticleIdList": ["10.1136/bmjopen-2020-039653", "PMC7925861", "33550227"]}, {"Citation": "Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u20132045. doi: 10.2215/CJN.11491116.", "ArticleIdList": ["10.2215/CJN.11491116", "PMC5718284", "28522654"]}, {"Citation": "Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med. 1991;324(23):1626\u20131632. doi: 10.1056/NEJM199106063242304.", "ArticleIdList": ["10.1056/NEJM199106063242304", "2030719"]}, {"Citation": "Tuttle KR, Puhlman ME, Cooney SK, Short RA. Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes. Am J Physiol Renal Physiol. 2002;282(1):F103\u2013F112. doi: 10.1152/ajprenal.00155.2001.", "ArticleIdList": ["10.1152/ajprenal.00155.2001", "11739118"]}, {"Citation": "Grabias BM, Konstantopoulos K. The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis. Am J Physiol Renal Physiol. 2014;306(5):F473\u2013F485. doi: 10.1152/ajprenal.00503.2013.", "ArticleIdList": ["10.1152/ajprenal.00503.2013", "24352503"]}, {"Citation": "de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Care. 2022;45(12):3075\u20133090. doi: 10.2337/dci22-0027.", "ArticleIdList": ["10.2337/dci22-0027", "PMC9870667", "36189689"]}, {"Citation": "Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861\u2013869. doi: 10.1056/NEJMoa011161.", "ArticleIdList": ["10.1056/NEJMoa011161", "11565518"]}, {"Citation": "Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851\u2013860. doi: 10.1056/NEJMoa011303.", "ArticleIdList": ["10.1056/NEJMoa011303", "11565517"]}, {"Citation": "Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295\u20132306. doi: 10.1056/NEJMoa1811744.", "ArticleIdList": ["10.1056/NEJMoa1811744", "30990260"]}, {"Citation": "Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436\u20131446. doi: 10.1056/NEJMoa2024816.", "ArticleIdList": ["10.1056/NEJMoa2024816", "32970396"]}, {"Citation": "Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol. 2018;71(13):1474\u20131482. doi: 10.1016/j.jacc.2018.01.058.", "ArticleIdList": ["10.1016/j.jacc.2018.01.058", "29598869"]}, {"Citation": "Fitchett D. A safety update on sodium glucose co-transporter 2 inhibitors. Diabetes Obes Metab. 2019;21(Suppl 2):34\u201342. doi: 10.1111/dom.13611.", "ArticleIdList": ["10.1111/dom.13611", "31081590"]}, {"Citation": "ShergisJohannah LY. Evidence-based clinical Chinese medicine volume 10 diabetic kidney disease. Singapore: World Scientifi; 2019."}, {"Citation": "Liu X, Ge M, Zhai X, Xiao Y, Zhang Y, Xu Z, et al. Traditional Chinese medicine for the treatment of diabetic kidney disease: a study-level pooled analysis of 44 randomized controlled trials. Front Pharmacol. 2022;13:1009571. doi: 10.3389/fphar.2022.1009571.", "ArticleIdList": ["10.3389/fphar.2022.1009571", "PMC9606328", "36313382"]}, {"Citation": "Zhang L, Yang L, Shergis J, Zhang L, Zhang AL, Guo X, et al. Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open. 2019;9(4):e025653. doi: 10.1136/bmjopen-2018-025653.", "ArticleIdList": ["10.1136/bmjopen-2018-025653", "PMC6501976", "31048437"]}, {"Citation": "Xue C, Lu C-J, Shergis J, Yang L. Evidence-based clinical Chinese medicine: volume 10: Diabetic Kidney Disease. 2019."}, {"Citation": "Lu Z, Zhong Y, Liu W, Xiang L, Deng Y. The efficacy and mechanism of Chinese herbal medicine on diabetic kidney disease. J Diabetes Res. 2019;2019:2697672. doi: 10.1155/2019/2697672.", "ArticleIdList": ["10.1155/2019/2697672", "PMC6732610", "31534972"]}, {"Citation": "Tang G, Li S, Zhang C, Chen H, Wang N, Feng Y. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B. 2021;11(9):2749\u20132767. doi: 10.1016/j.apsb.2020.12.020.", "ArticleIdList": ["10.1016/j.apsb.2020.12.020", "PMC8463270", "34589395"]}, {"Citation": "Liu M, Zhang Q, Huang K, Huang J, Sheng H, Chen J, et al. Tangshen Qushi Formula for patients with DKD: an open-label single-arm, exploratory clinical trial. Chin J Integr Tradit West Nephrol. 2022;23(4):1056\u201360."}, {"Citation": "Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kuli\u0107 \u017d, McGaw LJ, et al. Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research\u2014the ConPhyMP\u2014Guidelines12. Front Pharmacol. 2022;13:953205. doi: 10.3389/fphar.2022.953205.", "ArticleIdList": ["10.3389/fphar.2022.953205", "PMC9514875", "36176427"]}, {"Citation": "Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647.", "ArticleIdList": ["10.1136/bmj.g7647", "25555855"]}, {"Citation": "Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. doi: 10.1186/1471-2288-14-43.", "ArticleIdList": ["10.1186/1471-2288-14-43", "PMC4230647", "24667063"]}, {"Citation": "Leenaars M, Hooijmans CR, van Veggel N, ter Riet G, Leeflang M, Hooft L, et al. A step-by-step guide to systematically identify all relevant animal studies. Lab Anim. 2012;46(1):24\u201331. doi: 10.1258/la.2011.011087.", "ArticleIdList": ["10.1258/la.2011.011087", "PMC3265183", "22037056"]}, {"Citation": "Webpage. Royal Botanic Gardens of Kew 2023 [Available from: http://mpns.kew.org/mpns-portal/."}, {"Citation": "Webpage. Plants of the World Online 2023 [Available from: http://www.plantsoftheworldonline.org."}, {"Citation": "Webpage. National Center for Biotechnology Information 2023 [Available from: https://pubchem.ncbi.nlm.nih.gov/.", "ArticleIdList": ["PMC9825438", "36370100"]}, {"Citation": "Hickson LJ, Abedalqader T, Ben-Bernard G, Mondy JM, Bian X, Conley SM, et al. A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease. Stem Cells Transl Med. 2021;10(9):1304\u20131319. doi: 10.1002/sctm.19-0419.", "ArticleIdList": ["10.1002/sctm.19-0419", "PMC8380442", "34106528"]}, {"Citation": "Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u2013560. doi: 10.1136/bmj.327.7414.557.", "ArticleIdList": ["10.1136/bmj.327.7414.557", "PMC192859", "12958120"]}, {"Citation": "Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219. doi: 10.1136/bmj.326.7382.219.", "ArticleIdList": ["10.1136/bmj.326.7382.219", "PMC1125071", "12543843"]}, {"Citation": "Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785\u2013794. doi: 10.1111/biom.12817.", "ArticleIdList": ["10.1111/biom.12817", "PMC5953768", "29141096"]}, {"Citation": "Xu ZJ, Shu S, Li ZJ, Liu YM, Zhang RY, Zhang Y. Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-\u03b2/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues. Medicine (Baltimore) 2017;96(3):e5879. doi: 10.1097/MD.0000000000005879.", "ArticleIdList": ["10.1097/MD.0000000000005879", "PMC5279091", "28099346"]}, {"Citation": "Zhou J, Pan J, Xiang Z, Wang Q, Tong Q, Fang J, et al. Xiaokeyinshui extract combination, a berberine-containing agent, exerts anti-diabetic and renal protective effects on rats in multi-target mechanisms. J Ethnopharmacol. 2020;262:113098. doi: 10.1016/j.jep.2020.113098.", "ArticleIdList": ["10.1016/j.jep.2020.113098", "32726678"]}, {"Citation": "Zhang Q, Liu X, Sullivan MA, Shi C, Deng B. Protective effect of Yi Shen Pai Du formula against diabetic kidney injury via inhibition of oxidative stress, inflammation, and epithelial-to-mesenchymal transition in db/db mice. Oxid Med Cell Longev. 2021;2021:7958021.", "ArticleIdList": ["PMC8423573", "34504642"]}, {"Citation": "Fang D, Wan X, Deng W, Guan H, Ke W, Xiao H, et al. Fufang Xue Shuan Tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats. Exp Ther Med. 2012;4(5):871\u2013876. doi: 10.3892/etm.2012.680.", "ArticleIdList": ["10.3892/etm.2012.680", "PMC3493747", "23226741"]}, {"Citation": "Hu Y, Tang W, Liu W, Hu Z, Pan C. Astragaloside IV alleviates renal tubular epithelial-mesenchymal transition via CX3CL1-RAF/MEK/ERK signaling pathway in diabetic kidney disease. Drug Des Devel Ther. 2022;16:1605\u20131620. doi: 10.2147/DDDT.S360346.", "ArticleIdList": ["10.2147/DDDT.S360346", "PMC9166910", "35669284"]}, {"Citation": "Huang D, Shen P, Wang C, Gao J, Ye C, Wu F. Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis. Pharm Biol. 2022;60(1):990\u2013996. doi: 10.1080/13880209.2022.2067572.", "ArticleIdList": ["10.1080/13880209.2022.2067572", "PMC9132481", "35587919"]}, {"Citation": "Chen YJ, Kong L, Tang ZZ, Zhang YM, Liu Y, Wang TY, et al. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomed Pharmacother. 2019;111:1166\u20131175. doi: 10.1016/j.biopha.2019.01.030.", "ArticleIdList": ["10.1016/j.biopha.2019.01.030", "30841430"]}, {"Citation": "Zhang Y, Wang B, Guo F, Li Z, Qin G. Involvement of the TGF\u03b21- ILK-Akt signaling pathway in the effects of hesperidin in type 2 diabetic nephropathy. Biomed Pharmacother. 2018;105:766\u2013772. doi: 10.1016/j.biopha.2018.06.036.", "ArticleIdList": ["10.1016/j.biopha.2018.06.036", "29909344"]}, {"Citation": "Aboolian A, Urner S, Roden M, Jha JC, Jandeleit-Dahm K. Diabetic kidney disease: from pathogenesis to novel treatment possibilities. Handb Exp Pharmacol. 2022;274:269\u2013307. doi: 10.1007/164_2021_576.", "ArticleIdList": ["10.1007/164_2021_576", "35318511"]}, {"Citation": "He J, Hong Q, Chen X. Research advances in relationship between renal tubular damage and oxidative stress in diabetic kidney disease. Acad J Chin PLA Med Sch. 2019;40(5):491\u20133, 501."}]}], "History": [{"Year": "2023", "Month": "8", "Day": "28"}, {"Year": "2023", "Month": "12", "Day": "23"}, {"Year": "2024", "Month": "1", "Day": "15", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "13", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "12", "Hour": "23", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["38217017", "PMC10785383", "10.1186/s13643-023-02446-4", "10.1186/s13643-023-02446-4"]}}]}